Alembic Pharmaceuticals’ JV gets EIR from USFDA for facility at Karkhadi

06 May 2019 Evaluate

Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture (JV) between Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection carried out by them at Aleor's Formulation Facility at Karakhadi, Gujarat, India during the period from February 04, 2019 to February 08, 2019.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

646.25 -30.80 (-4.55%)
23-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1756.35
Dr. Reddys Lab 1252.55
Cipla 1222.70
Zydus Lifesciences 860.55
Lupin 2297.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×